News
-
OthersNEW Notice Regarding Delivery of Restricted Shares to Corporate Executive Officers and Executive Officers
-
InformationRelief Aid for Victims of the Earthquake in Eastern Taiwan
-
BusinessComponents with Compliant Mechanism Design Adopted for Lunar Rover YAOKI
-
BusinessRADICAVA ORS® as Orphan drug designation and approval in US
-
InformationMedtec Japan, design and Manufacture of medical device trade show 2024
-
OthersNEW Notice Regarding Delivery of Restricted Shares to Corporate Executive Officers and Executive Officers
-
BusinessComponents with Compliant Mechanism Design Adopted for Lunar Rover YAOKI
-
BusinessRADICAVA ORS® as Orphan drug designation and approval in US
-
BusinessBiomass-based Polycarbonatediol “BENEBiOL” Adopted for the Watch Band of Citizen Watch
-
OthersMessage from Manabu Chikumoto, Representative Corporate Executive Officer, President and Chief Executive Officer of Mitsubishi Chemical Group Corporation,
for 2024 Career Kick-off Session (Summary)
-
InformationRelief Aid for Victims of the Earthquake in Eastern Taiwan
-
InformationMedtec Japan, design and Manufacture of medical device trade show 2024
-
InformationTranscript of Financial Results Presentation for Q3 of the Fiscal Year Ending March 31, 2024
-
InformationNotice of update of the MCG Group website
-
InformationNew article from web media KAITEKI Solution Center: The lunar rover YAOKI's exteriorーcrafted almost entirely by the Group
-
TSE FilingsNotice Concerning Change of Major Shareholder
-
IR NewsTranscript of Financial Results Presentation for Q3 of the Fiscal Year Ending March 31, 2024
-
TSE FilingsNotice Regarding Change (Appointed) of Representative Corporate Executive Officer
-
TSE FilingsNotice Regarding Change (Retirement) of Representative Corporate Executive Officer
-
IR NewsAnnouncement of Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2024 (Operational Summary)
Corporate Information
Group information on Mitsubishi Chemical Group Corporation, which is confronting uncertainty with a continued transformation.
Investor Relations
About IR information of Mitsubishi Chemical Group Corporation, which is enhancing its asset efficiency and refortifying its financial base in an effort to enhance corporate value.
Innovation
We introduce the innovations of the Mitsubishi Chemical Group, which we are pursuing as a driving force that supports sustained growth, across industries and across countries.
Sustainability
The Mitsubishi Chemical Group will work on solving social issues through business activities, contribute to the sustainable development of the global environment and society, and realize the Group’s sustainable growth.